These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21900196)

  • 21. Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.
    Belizaire R; Kim HT; Poryanda SJ; Mirkovic NV; Hipolito E; Savage WJ; Reynolds CG; Fields MJ; Whangbo J; Kubo T; Nikiforow S; Alyea EP; Armand P; Cutler CS; Ho VT; Blazar BR; Antin JH; Ritz J; Soiffer RJ; Koreth J
    Blood Adv; 2019 Apr; 3(7):969-979. PubMed ID: 30936057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation.
    Schneider M; Munder M; Karakhanova S; Ho AD; Goerner M
    Clin Lab Haematol; 2006 Dec; 28(6):382-90. PubMed ID: 17105491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
    Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
    Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.
    Ukena SN; Geffers R; Buchholz S; Stadler M; Franzke A
    Transpl Immunol; 2012 Dec; 27(4):179-83. PubMed ID: 22889700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.
    Zorn E; Mohseni M; Kim H; Porcheray F; Lynch A; Bellucci R; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):382-8. PubMed ID: 19203731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
    Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
    Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
    Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
    J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune modulation and chronic graft-versus-host disease.
    Soiffer R
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S66-S69. PubMed ID: 18724307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.
    Koreth J; Kim HT; Jones KT; Lange PB; Reynolds CG; Chammas MJ; Dusenbury K; Whangbo J; Nikiforow S; Alyea EP; Armand P; Cutler CS; Ho VT; Chen YB; Avigan D; Blazar BR; Antin JH; Ritz J; Soiffer RJ
    Blood; 2016 Jul; 128(1):130-7. PubMed ID: 27073224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
    Matsuoka K; Kim HT; McDonough S; Bascug G; Warshauer B; Koreth J; Cutler C; Ho VT; Alyea EP; Antin JH; Soiffer RJ; Ritz J
    J Clin Invest; 2010 May; 120(5):1479-93. PubMed ID: 20389017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT.
    Copsel SN; Lightbourn CO; Barreras H; Lohse I; Wolf D; Bader CS; Manov J; Kale BJ; Shah D; Brothers SP; Perez VL; Komanduri KV; Wahlestedt C; Levy RB
    Front Immunol; 2018; 9():3104. PubMed ID: 30733722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T memory stem cells after allogeneic haematopoietic cell transplantation: unique long-term kinetics and influence of chronic graft-versus-host disease.
    Jimbo K; Konuma T; Watanabe E; Kohara C; Mizukami M; Nagai E; Oiwa-Monna M; Mizusawa M; Isobe M; Kato S; Takahashi S; Tojo A
    Br J Haematol; 2019 Sep; 186(6):866-878. PubMed ID: 31135974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease.
    Whangbo JS; Nikiforow S; Kim HT; Wahl J; Reynolds CG; Rai SC; Kim S; Burden A; Alho AC; Lacerda JF; Alyea EP; Cutler CS; Ho VT; Antin JH; Soiffer RJ; Ritz J; Koreth J
    Blood Adv; 2022 Nov; 6(21):5786-5796. PubMed ID: 35475885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.
    Anderson BE; McNiff JM; Matte C; Athanasiadis I; Shlomchik WD; Shlomchik MJ
    Blood; 2004 Sep; 104(5):1565-73. PubMed ID: 15150080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of the CD4+CD25high T-regulatory cells in recipients and their corresponding donors to acute GVHD.
    Zhai Z; Sun Z; Li Q; Zhang A; Liu H; Xu J; Xu X; Geng L; Harris D; Hu S; Wang Y
    Transpl Int; 2007 May; 20(5):440-6. PubMed ID: 17313446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-2 and regulatory T cells in graft-versus-host disease.
    Koreth J; Matsuoka K; Kim HT; McDonough SM; Bindra B; Alyea EP; Armand P; Cutler C; Ho VT; Treister NS; Bienfang DC; Prasad S; Tzachanis D; Joyce RM; Avigan DE; Antin JH; Ritz J; Soiffer RJ
    N Engl J Med; 2011 Dec; 365(22):2055-66. PubMed ID: 22129252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner.
    McDonald-Hyman C; Flynn R; Panoskaltsis-Mortari A; Peterson N; MacDonald KP; Hill GR; Luznik L; Serody JS; Murphy WJ; Maillard I; Munn DH; Turka LA; Koreth J; Cutler CS; Soiffer RJ; Antin JH; Ritz J; Blazar BR
    Blood; 2016 Aug; 128(7):1013-7. PubMed ID: 27385791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.
    Meignin V; Peffault de Latour R; Zuber J; Régnault A; Mounier N; Lemaître F; Dastot H; Itzykson R; Devergie A; Cumano A; Gluckman E; Janin A; Bandeira A; Socié G
    Exp Hematol; 2005 Aug; 33(8):894-900. PubMed ID: 16038781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.
    Yamashita K; Choi U; Woltz PC; Foster SF; Sneller MC; Hakim FT; Fowler DH; Bishop MR; Pavletic SZ; Tamari M; Castro K; Barrett AJ; Childs RW; Illei GG; Leitman SF; Malech HL; Horwitz ME
    Blood; 2004 May; 103(10):3986-8. PubMed ID: 14764530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
    Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
    Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.